Sysmex to Introduce New Analyzer for Detecting Breast Cancer Lymph-Node Metastasis to European Market.Tokyo, Japan, Apr 21, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Sysmex announced on April 20 that it will introduce the gene amplification Gene amplification The process by which a cell specifically increases the copy number of a particular gene to a greater extent than it increases the copy number of genes composing the remainder of the genome (all the genes which make up the genetic machinery detector RD-100i and related reagents in the European market. The RD-100i analyzer, which is based on the company's proprietary gene amplification method OSNA OSNA Ornithological Societies of North America OSNA Oregon Student Nurses Association OSNA Open Service Network Architecture (One-step Nucleic Acid Amplification), can determine the status of lymph-node metastasis metastasis /me·tas·ta·sis/ (me-tas´tah-sis) pl. metas´tases 1. transfer of disease from one organ or part of the body to another not directly connected with it, due either to transfer of pathogenic microorganisms or to of breast cancer in about 30 minutes during an operation. The company plans to introduce the same analyzer in Japan and the US in fiscal 2007. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion